Consumer health is expected to see continued current value growth in Canada in 2024. The year is set to represent another step in the transition from the pandemic-era and a 2022 marked by extreme demand and cough, cold and analgesics shortages caused by the “triple-demic” of flu, respiratory syncytial virus (RSV) and COVID-19. Growth is expected despite headwinds from an inflation-driven higher cost of living including high housing costs, and budget conscious consumers being cautious in their sp...
Euromonitor International's Consumer Health in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Consumer Health in Canada
Euromonitor International
September 2024
List Of Contents And Tables
CONSUMER HEALTH IN CANADA
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 2 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2019-2024
Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN CANADA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Slight fall in sales of systemic analgesics as demand normalises
Innovation in topical analgesics/anaesthetic
Extended wait for surgery boosts demand for analgesics
PROSPECTS AND OPPORTUNITIES
Positive outlook for analgesics
Tylenol joins up with NHL
Demographic developments favour expansion of topical analgesics/anaesthetic category
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2019-2024
Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN CANADA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Normalisation of demand continues
Strong demand for antihistamines/allergy remedies (systemic)
Immunity boosting vitamins and dietary supplements compete with OTC cough and cold remedies
PROSPECTS AND OPPORTUNITIES
OTC cough and cold remedies to see continued transition to more normal demand levels
Warmer temperatures expected to boost demand for antihistamines/allergy remedies
Strong private label competition
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
DIGESTIVE REMEDIES IN CANADA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Consistent demand for digestive remedies
Viome launch highlights trends in approaches to digestive health
Ongoing innovation
PROSPECTS AND OPPORTUNITIES
Positive outlook, but not without challenges
New developments highlight growing sophistication of consumer awareness
Private label to continue to present significant competition to brands
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
DERMATOLOGICALS IN CANADA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Ageing population resumes role as key growth driver
Lice outbreaks at schools supporting demand for antiparasitics/lice (head and body) treatments
Private label offers strong competition
PROSPECTS AND OPPORTUNITIES
Growing demand for relief from insect bites
Growing competition from mass dermocosmetics
Adults increasingly using nappy (diaper) rash treatments
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2019-2024
Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
NRT SMOKING CESSATION AIDS IN CANADA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Growth driven by consistent desire to quit smoking
Governmental support for smokers to quit
McNeil Consumer Healthcare dominates
PROSPECTS AND OPPORTUNITIES
Difficulties in quitting smoking to drive consistent demand
Ongoing private label presence, while e-commerce set to develop further
Nicotine pouches cause controversy
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2019-2024
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029
SLEEP AIDS IN CANADA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Increasing incidence of sleep problems supports demand